Why Cornerstone Robotics’ Sentire CE Mark could shake up Europe’s surgical robotics market
Cornerstone Robotics has cleared Europe’s MDR bar for Sentire. The real test is whether surgical robotics can scale beyond elite hospitals.
Is Butterfly Medical’s prostate retraction device the next challenger in minimally invasive BPH treatment?
BPH care needs options beyond pills and surgery. Butterfly Medical’s $21m raise puts its reversible prostate implant in the spotlight.
Medtronic just cleared a key ECMO transport hurdle, but hospitals still face the harder test
ECMO transport is a clinical weak point. Medtronic’s VitalFlow CE mark tests whether device mobility can strengthen critical care networks.
Can Microsure turn MUSA-3’s CE mark into real hospital adoption in Europe?
Microsure has European clearance for MUSA-3. Now hospitals must decide whether robotic microsurgery can justify adoption.
Why Johnson & Johnson’s new ETHICON 4000 stapler could matter for European surgical workflow economics
Read how Johnson & Johnson’s ETHICON 4000 CE Mark approval could reshape surgical stapling, hospital economics, and future robotic integration.
Profusa Lumee Oxygen gains pre-approval orders as EU MDR decision looms
Profusa secures Lumee Oxygen orders ahead of EU MDR clearance. Discover what this means for CLTI monitoring and 2026 commercialization.
Gore’s TIPS expansion device wins CE mark: Could 6–10 mm range reshape portal hypertension shunt strategies?
Gore’s VIATORR device earns CE mark for 6–10 mm range, enabling tailored TIPS procedures. Find out how this could reshape portal hypertension care.
Medtronic expands Affera platform with Sphere-360 catheter CE Mark and IDE trial kickoff
Medtronic’s Sphere-360 catheter earns CE Mark and begins U.S. IDE trial. Find out what this means for the future of pulsed field ablation.
May Health’s Anavi System CE Mark highlights a new middle ground in PCOS infertility treatment
May Health’s Anavi System wins CE Mark. Find out what this means for PCOS infertility care, clinical adoption, and regulatory pathways in Europe.
What Nitinotes’ EASE trial tells us about the future of bariatric endoscopy
Nitinotes Ltd. has begun patient enrollment in its pivotal U.S. Investigational Device Exemption study evaluating the EndoZip Automated Suturing System for endoscopic sleeve gastroplasty (ESG). The first procedure in the EASE Clinical Trial was completed at Lenox Hill Hospital | Northwell Health in New York, marking the U.S. debut of the device. This study pits […]